Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Praxis Precision Medicines Inc
PRAXCurrent price
68.33 USD
-2.23 USD (-3.16%)
Last closed
69.99 USD
Company
www.praxismedicines.com
ISIN
US74006W1080
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 286 324 992 USD
Yield for 12 month
+306.73 %
1Y
3Y
5Y
10Y
15Y
PRAX
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts. Address: 99 High Street, Boston, MA, United States, 02110
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
146.44 USDP/E ratio
–Dividend Yield
–Current Year
+2 447 000 USD
Last Year
+1 464 000 USD
Current Quarter
+357 000 USD
Last Quarter
+431 000 USD
Current Year
+2 015 000 USD
Last Year
-1 171 000 USD
Current Quarter
+250 000 USD
Last Quarter
+319 000 USD
Key Figures PRAX
1 year
3 years
5 years
10 years
EBITDA
-132 257 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.87 %
PEG Ratio
–
Return On Equity TTM
-47.16 %
Wall Street Target Price
146.44 USD
Revenue TTM
1 771 000 USD
Book Value
23.6 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-54.3 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-5.59 USD
Diluted Eps TTM
-5.59 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PRAX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PRAX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
29.11.2023
Dividend Date
–
Stock Valuation PRAX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
519.7107
Price Sales TTM
726.3269
Enterprise Value EBITDA
-6.8585
Price Book MRQ
3.0311
Financials PRAX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PRAX
For 52 weeks
13.01 USD
75.73 USD
50 Day MA
60.7 USD
Shares Short Prior Month
1 798 488
200 Day MA
51.28 USD
Short Ratio
5.84
Shares Short
1 715 969
Short Percent
9.68 %
BeatStart